Affordable Care Act (ACA) enrollment was stable in most places despite turmoil; National Institutes of Health research, opioid, and mental health funding see gains in budget deal, but ACA stabilization plan is missing.
Affordable Care Act (ACA) plan enrollment declined slightly, but states running their own marketplaces saw slight gains and did better than those relying on the federal exchange. About 11.8 million Americans enrolled in 2018 coverage, down 3.7% from last year’s total, according to the National Academy for State Health Policy, Kaiser Health News reported. The enrollment period was marked by a shorter time frame, a sharply reduced federal budget for outreach, and confusion during months of repeal-and-replace debate.
Funding for research at the National Institutes of Health would rise by $2 billion and spending to address opioid and mental health issues would rise by $6 billion over the next 2 years under a bipartisan budget agreement announced by Senate leaders, STAT reported. The White House endorsed the agreement and the House is also likely to pass it.
Last December, Senate Majority Leader Mitch McConnell, R-Kentucky, promised Senator Susan Collins, R-Maine, a vote on shoring up the ACA’s individual health insurance marketplaces in exchange for her vote for the GOP tax bill. So far, that vote has not materialized and is not included in the bipartisan budget agreement reached late Wednesday, Kaiser Health News reported. The deal does include most of the Democrats' other health priorities.
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps
April 15th 2025Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.
Read More
Health Equity & Access Weekly Roundup: April 14, 2025
April 14th 2025From the potential impact of tariffs to the World Health Organization's year-long campaign launch focused on improving maternal and newborn health and addressing preventable deaths, here's the latest from the Center on Health Equity & Access.
Read More